-
LBA83 Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): A multicenter randomized controlled trial2023 Annals of Oncology conference-abstract Medicine Pancreatic and Hepatic Oncology Research Open access
Bas Groot Koerkamp, Quisette P. Janssen, Jacob L. van Dam, Bert A. Bonsing, H. J. M. Bos, Koop P Bosscha, +14 more
59citations -
LBA75 Neoadjuvant chemoradiotherapy followed by surgery versus active surveillance for oesophageal cancer (SANO-trial): A phase-III stepped-wedge cluster randomised trial2023 Annals of Oncology conference-abstract Medicine Esophageal Cancer Research and Treatment Open access
Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, Camiel Rosman, Bo Jan Noordman, +14 more
52citations -
LBA42 Distant metastasis-free survival of neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in resectable, macroscopic stage III melanoma: The NADINA trial2024 Annals of Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management Open access
M.W. Lucas, Alexander Maxwell Menzies, Marta López‐Yurda, Richard A. Scolyer, Bart A. van de Wiel, Robyn P.M. Saw, +14 more
14citations -
LBA57 Two-year clinical update and first biomarker analyses of the phase III NADINA trial comparing neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in resectable stage III melanoma2025 Annals of Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
M.W. Lucas, Alexander Maxwell Menzies, Petros Dimitriadis, S C M A Wijnen, Marta López‐Yurda, Richard A. Scolyer, +13 more
11citations -
LBA56 Updated efficacy and safety from the phase II PHAROS study of encorafenib plus binimetinib in patients with BRAF V600E-mutant metastatic NSCLC (mNSCLC)2024 Annals of Oncology conference-abstract Medicine Lung Cancer Treatments and Mutations Open access
G.J. Riely, M-J. Ahn, Jade Clarke, Ibiayi Dagogo‐Jack, E. Felip, Francesco Gelsomino, +14 more
10citations -
LBA74 Zongertinib as first-line treatment in patients with advanced HER2-mutant NSCLC: Beamion LUNG 12025 Annals of Oncology conference-abstract Medicine Lung Cancer Treatments and Mutations Open access
Sanjay Popat, Norio Yamamoto, Nicolas M Girard, Yi-Long Lung Cancer Wu, Gerrina Ruiter, Egbert Frederik Smit, +8 more
8citations -
LBA71 First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (uMPM): 4-year update from CheckMate 7432022 Annals of Oncology conference-abstract Medicine Occupational and environmental lung diseases Open access
Gérard Zalcman, Y. Oulkhouir, Robin Cornelissen, Laurent Greillier, Jerónimo Rodríguez Cid, Julien Mazières, +12 more
7citations -
LBA59 Combined percutaneous hepatic perfusion with ipilimumab plus nivolumab in metastatic uveal melanoma (CHOPIN): A single-center, open-label, randomized, phase II study
E. Kapiteijn, Frank M. Speetjens, Stephanie M. Zunder, Arian R. van Erkel, Carla van Rijswijk, Jacob Lutjeboer, +11 more
5citations -
LBA12 5-year follow-up results from the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial2025 Annals of Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
O. Pagani, Samuel M. Niman, Fedro Alessandro Peccatori, Hatem A. Azim, M.A. Colleoni, Cristina Saura, +10 more
5citations -
O-13 Efficacy and safety of ripretinib as ≥4th-line therapy for patients with gastrointestinal stromal tumor following crossover from placebo: Analyses from INVICTUS2020 Annals of Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment Open access
César Serrano, Michael Charles Heinrich, Suzanne George, John Raymond Zalcberg, Sebastian Bauer, Hans A. J. Gelderblom, +11 more
4citations -
P-384 Quality of life and the systemic pharmacokinetics of oxaliplatin in patients with unresectable peritoneal metastases from colorectal cancer treated with repetitive electrostatic pressurized intraperitoneal aerosol chemotherapy (ePIPAC): The CRC-PIPAC trial2020 Annals of Oncology conference-abstract Medicine Intraperitoneal and Appendiceal Malignancies Open access
Robin J. Lurvink, Koen P. B. Rovers, Rudaba Tajzai, Emma C. E. Wassenaar, Floortje Mols, Dirk Jan A. R. Moes, +7 more
2citations -
LBA78 Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial2024 Annals of Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments Open access
H. Gelderblom, Vivek A. Bhadri, S. Stacchiotti, Sebastian Bauer, Andrew J. Wagner, Meike van de Sande, +12 more
1citations -
P-288 Nerve fibers in the tumour microenvironment are co-localized with tertiary lymphoid structures and is associated with better survival in pancreatic cancer patients2020 Annals of Oncology conference-abstract Medicine Pancreatic and Hepatic Oncology Research Open access
Lara Rosaline Heij, Jakob Nikolas Kather, Shivan Sivakumar, Nadine Therese Gaisa, Georg J. Wiltberger, Ulf P. Neumann
0citations -
SO-16 The tumour-stroma ratio as an additional parameter to the TNM classification: The UNITED study2020 Annals of Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Wilma E. Mesker, Marloes A. Smit, Gabi W. van Pelt, Hans A. J. Gelderblom, J. Han van Krieken, R.A.E.M. Tollenaar
0citations -
P-101 Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2019: A population-based study2022 Annals of Oncology conference-abstract Medicine Esophageal Cancer Research and Treatment Open access
Marieke Pape, Steven C. Kuijper, P.A. Vissers, Jelle P. H. Ruurda, Karen J. Neelis, Hanneke W.M. van Laarhoven, +1 more
0citations -
LBA31 Neoadjuvant immunotherapy induces immune activation and responses in MMR-proficient colon cancers2025 Annals of Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Yara L. Verschoor, Pedro Batista Tan, José G. van den Berg, Sara Balduzzi, Niels F.M. Kok, Marieke E. Ijsselsteijn, +10 more
0citations -
P-104 Risk of nausea and vomiting in a real-world data cohort of chemotherapy-treated patients with metastatic gastric or gastroesophageal junction adenocarcinoma by medical history of gastrectomy2021 Annals of Oncology conference-abstract Medicine Gastric Cancer Management and Outcomes Open access
Stefan de Vogel, James Van Schyndle, David Nimke, Ahsan M. Arozullah, Noah Jamie Robinson
0citations
18 results